Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Interventional × Motivational Interviewing × Clear all

Phase

Status

Completed 19 Unknown 5 Not yet recruiting 3 Active not recruiting 3 Withdrawn 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Medication Adherence 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 102 Cisplatin 100 Radiotherapy 98 pembrolizumab 93 Paclitaxel 76 Carboplatin 74 Gemcitabine 71 Nivolumab 68 Fluorouracil 64 Magnetic Resonance Spectroscopy 63 Dexamethasone 57 Bevacizumab 57 Radiosurgery 53 Docetaxel 52 Rituximab 48 Oxaliplatin 48 Leucovorin 48 fludarabine 45 Capecitabine 45 Biopsy 40 Doxorubicin 39 durvalumab 37 fludarabine phosphate 35 Etoposide 35 Drug Therapy 35 Cytarabine 35 Pemetrexed 34 Radiation 33 Lenalidomide 32 Irinotecan 30

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02883361 2024-12-05

MI for AIs

University of Calgary

Phase 2/3 Withdrawn

Breast Neoplasms, Medication Adherence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡